Answers are grounded in this paper and cite their sources.
Objectives To evaluate whether preoperative supplementation with an omega-3/vitamin E-containing formulation was associated with differences in the tissue inflammatory and redox biomarker profile of persistent asymptomatic periapical lesions requiring endodontic microsurgery. Materials and methods This prospective non-randomized controlled clinical study included adult patients with persistent asymptomatic post-treatment apical periodontitis in previously treated teeth requiring endodontic microsurgery. Participants were allocated to a control group or to a supplementation group receiving omega-3/vitamin E for 40 days before surgery. Periapical lesion tissues were collected during surgery, and laboratory analyses were performed with laboratory personnel blinded to group allocation. Tissue extracts were analysed for inflammatory cytokines, matrix-related biomarkers, and oxidative stress markers. Sixteen participants were included in the final per-protocol analysis ( n = 8 per group). Results Compared with the control group, the omega-3/vitamin E group showed significantly lower tissue levels of pro-inflammatory cytokines, including IL-6 and TNF-α. The supplemented group also exhibited significantly lower levels of MMP-2, VEGF-A and TBARS, together with significantly higher levels of IFN-γ, IL-13 and PDGF-AB/BB. No significant differences between-group were observed for IL-1β, IL-4, IL-10, IL-17 A, MCP-1, MMP-9, or protein carbonyl levels. Conclusions Preoperative omega-3/vitamin E supplementation was associated with a distinct molecular profile characterized by reduced inflammatory and oxidative stress markers and selective changes in immunoregulatory mediators. These findings suggest modulation of the lesional microenvironment but should be interpreted as exploratory. Clinical Relevance Host-modulatory strategies such as omega-3/vitamin E supplementation may influence the local biological profile of persistent apical lesions, although their clinical impact remains to be determined. Trial registration This study was registered in the Brazilian Clinical Trials Registry — ReBEC, under registration number RBR-9mjf86. ( https://ensaiosclinicos.gov.br/rg/RBR-9mjfj86 )
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: